Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Clinical trial NCT01837251 · COMPLETED
Trial details
- NCT number
- NCT01837251
- Sponsor
- AGO Research GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2021-01-01
- Enrollment
- 682
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.